糖尿病病程、血糖控制与颅内动脉粥样硬化斑块易损性
回顾性纳入220例缺血性卒中或TIA患者,于症状发作4周内行3T高分辨率磁共振血管壁成像,评估责任斑块特征。糖尿病病程≥10年与正性重构相关,HbA1c≥7.0%与斑块内出血、斑块强化及表面不规则相关;病程≥10年及HbA1c≥7.0%者全部易损斑块特征共存率均高于非糖尿病患者。
要点
- 糖尿病病程≥10年者正性重构率高于病程<10年者(校正OR=2.9,95%CI 1.2-6.9)。
- HbA1c≥7.0%者斑块内出血率高于HbA1c<7.0%者(校正OR=9.14,95%CI 2.66-31.33)。
- HbA1c≥7.0%者斑块强化及表面不规则率均高于HbA1c<7.0%者(校正OR分别为3.09和2.72)。
核心结论
- 糖尿病病程增加和血糖控制不佳均与颅内动脉粥样硬化斑块易损性的存在及共存独立相关,在颅内动脉粥样硬化患者风险分层时应考虑这两项因素。
研究设计与样本
- 回顾性纳入220例缺血性卒中或TIA患者,于症状发作4周内行3T高分辨率磁共振血管壁成像,评估责任斑块形态(正性重构、表面不规则)和激活(斑块内出血、斑块强化),采用多变量logistic回归分析。
关键影像表现/征象
- 责任斑块易损特征包括斑块内出血、表面不规则、正性重构和斑块强化。
- 糖尿病病程≥10年与正性重构相关(校正OR=2.9,95%CI 1.2-6.9)。
- HbA1c≥7.0%与斑块内出血相关(校正OR=9.14,95%CI 2.66-31.33)。
- HbA1c≥7.0%与斑块强化相关(校正OR=3.09,95%CI 1.02-9.34)。
- HbA1c≥7.0%与表面不规则相关(校正OR=2.72,95%CI 1.04-7.11)。
诊断标准与关键数值
- 糖尿病病程≥10年者全部易损斑块特征共存率高于非糖尿病患者(校正OR=3.84,95%CI 1.31-11.24)。
- HbA1c≥7.0%者全部易损斑块特征共存率高于非糖尿病患者(校正OR=3.41,95%CI 1.33-8.76)。
临床应用与阅片要点
- 阅片评估颅内动脉粥样硬化斑块时,可将糖尿病病程≥10年及HbA1c≥7.0%作为提示斑块易损性的临床信息。
- 报告斑块特征时需关注正性重构、斑块内出血、斑块强化及表面不规则,尤其对血糖控制不佳或糖尿病病程较长者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Intracranial vulnerable plaque, characterized by intraplaque hemorrhage (IPH), surface irregularity, positive remodeling, and plaque enhancement, is associated with cerebrovascular events. History of diabetes mellitus (DM) was reported to be a potential predictor of plaque vulnerability, but the predictive value of DM-related variables for it is still uncertain. The purpose of this study was to investigate the association of diabetes duration and glycemic control with symptomatic plaque vulnerability, in comparison to non-diabetic patients.
METHODS: We retrospectively included a total of 220 patients who presented with ischemic stroke or transient ischemic attacks (TIA) underwent 3 T high-resolution magnetic resonance vessel wall imaging within 4 weeks of the onset of symptoms. The culprit plaque characteristics including morphology (positive remodeling and surface irregularity) and activation (IPH and plaque enhancement) were evaluated. We used multivariable logistic regression analyses to assess the differences of duration of diabetes (≥10 years compared with < 10 years) and glycemic control (HbA1c values ≥ 7.0 % compared with < 7.0 %) in plaque characteristics.
RESULTS: The sample (n = 220) had a mean age of 56.6 ± 11.9 years and was 46.4 % of diabetes. Of the 102 DM individuals, 58.8 % had been with DM duration < 10 years (Short-DM group) and 41.2 % with duration ≥ 10 years (Long-DM group). The well-controlled group (HbA1c values < 7.0 %) and poor-controlled DM group (HbA1c values ≥ 7.0 %) included 31 (30.4 %) and 71 (69.6 %) patients, respectively. We found significant difference in positive remodeling between patients with DM duration < 10 years and ≥ 10 years (adjusted odds ratio [OR] = 2.9 [95 % CI, 1.2-6.9]). Compared with patients who had HbA1c < 7.0 %, poor glycemic control was significantly associated with an increased rate of IPH (adjusted OR = 9.14 [95 % CI, 2.66-31.33]), plaque enhancement (adjusted OR = 3.09 [95 % CI, 1.02-9.34]), and surface irregularity (adjusted OR = 2.72 [95 % CI, 1.04-7.11]). Both patients with duration ≥ 10 years (adjusted OR = 3.84 [95 % CI, 1.31-11.24]) and patients HbA1c ≥ 7.0 % (adjusted OR = 3.41 [95 % CI, 1.33-8.76]) had more often coexistence of all vulnerable plaque characteristics compared with nondiabetic patients.
CONCLUSION: Increased durations of diabetes and poor glycemic control are both independently associated with existence and coexistence of intracranial atherosclerotic plaque vulnerability, which should be considered when stratifying risk among patients with intracranial atherosclerosis.
引用
- Huang Q, Liu W, Sun L, et al. Duration of diabetes, glycemic control and intracranial atherosclerotic plaque vulnerability. Eur J Radiol. 2025. PMID: 40784069. doi:10.1016/j.ejrad.2025.112347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。